Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, Myeloid × IPI-549 × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1 Leukemia, Myeloid 1 Leukemia 1

Interventions

venetoclax 2 ponatinib 1 fludarabine phosphate 1 fludarabine 1 aldesleukin 1 Whole-Body Irradiation 1 Tacrolimus 1 Photography 1 Peripheral Blood Stem Cell Transplantation 1 Patient Reported Outcome Measures 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Interleukin-2 1 IPI-549 1 Cyclophosphamide 1 Busulfan 1 Bone Marrow Transplantation 1 Biopsy 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07439211 2026-03-03

GAVEL

Dana-Farber Cancer Institute

Phase 1 Not yet recruiting

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡